Only a few loose hands have sold, let's see what happens throughout the day. I am happy with the result.
Printable View
I know the focus is the US, but isn't it worrying to see that in NZ, where they actually have the support of most of the DHB's (albeit at about 1/4 of the price charged per test), where they are actually using the full suite of Cxbladder tests and are in the clinical pathway, that sales here amounted to a miserable $900k for the six months compared to $2.1m the full year before?
A billion dollar Company with sales of $5m for six months. This after apparent CMS approval, Kaiser, United, blah de blah.
Insane
Total Revenue increased 66%
Total Laboratory Throughput (TLT) increased 62%
Commercial test volumes increased 64%
Cash receipts from customers increased 110%
Operating expenses increased 41%
$100m in the bank